| Clinical observations and outcomes of radiofrequency catheter ablation to the pulmonary veins for atrial fibrillation | |
|
Principal Investigator: Kevin Wheelan, M. D. Location: Baylor Heart and Vascular Hosptial Sub-Investigators: Peter Wells, M.D. Sponsor: HeartPlace Primary Objective: (1) Prospective data collection to identify the sub-population of patients with atrial fibrillation who have the largest long-term reduction in atrial fibrillation. (2) Identification of the current FDA-approved RF catheter ablation technology with the highest incidence of long-term success and the fewest procedure-related complications. Contact Information: Cory White (214.820.7825) |
|
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
